The Regents of the University of Colorado; a Body Corporate
发明人:
REIGAN, Philip,BACKOS, Donald S.,MATHESON, Christopher J.,CASALVIERI, Kimberly A.
申请号：
AU2019227823
公开号：
AU2019227823A1
申请日:
2019.02.28
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
A compound, or a pharmaceutically acceptable salts or prodrugs thereof, having the chemical structure (I) and methods of using these compounds to inhibit WEE1 kinase and treat cancer in a subject.
